FI963073L - Makrosykliset difluorisatonijohdannaiset, jotka ovat käyttökelpoisia viruksia vastustavina aineina - Google Patents

Makrosykliset difluorisatonijohdannaiset, jotka ovat käyttökelpoisia viruksia vastustavina aineina Download PDF

Info

Publication number
FI963073L
FI963073L FI963073A FI963073A FI963073L FI 963073 L FI963073 L FI 963073L FI 963073 A FI963073 A FI 963073A FI 963073 A FI963073 A FI 963073A FI 963073 L FI963073 L FI 963073L
Authority
FI
Finland
Prior art keywords
difluorozatone
macrocyclic
antiviral agents
derivatives useful
derivatives
Prior art date
Application number
FI963073A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963073A7 (fi
FI963073A0 (fi
Inventor
Robert A Farr
Brent L Podlogar
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of FI963073A7 publication Critical patent/FI963073A7/fi
Publication of FI963073L publication Critical patent/FI963073L/fi
Publication of FI963073A0 publication Critical patent/FI963073A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI963073A 1994-02-04 1994-11-28 Makrosykliset difluorisatonijohdannaiset, jotka ovat käyttökelpoisia viruksia vastustavina aineina FI963073A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19208094A 1994-02-04 1994-02-04
PCT/US1994/013711 WO1995021186A1 (fr) 1994-02-04 1994-11-28 Derives de difluorostatone macrocyclique utiles en tant qu'agents antiviraux

Publications (3)

Publication Number Publication Date
FI963073A7 FI963073A7 (fi) 1996-08-02
FI963073L true FI963073L (fi) 1996-08-02
FI963073A0 FI963073A0 (fi) 1996-08-02

Family

ID=22708156

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963073A FI963073A0 (fi) 1994-02-04 1994-11-28 Makrosykliset difluorisatonijohdannaiset, jotka ovat käyttökelpoisia viruksia vastustavina aineina

Country Status (20)

Country Link
US (1) US5969132A (fr)
EP (1) EP0742791B1 (fr)
JP (1) JP3574455B2 (fr)
KR (1) KR100367379B1 (fr)
CN (1) CN1142830A (fr)
AT (1) ATE198602T1 (fr)
AU (1) AU684875B2 (fr)
CA (1) CA2182476C (fr)
DE (1) DE69426574T2 (fr)
DK (1) DK0742791T3 (fr)
ES (1) ES2155515T3 (fr)
FI (1) FI963073A0 (fr)
GR (1) GR3035623T3 (fr)
HU (1) HUT74384A (fr)
IL (1) IL112514A0 (fr)
NO (1) NO963254L (fr)
NZ (1) NZ277410A (fr)
PT (1) PT742791E (fr)
WO (1) WO1995021186A1 (fr)
ZA (1) ZA95756B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004025569D1 (de) 2003-06-18 2010-04-01 Tranzyme Pharma Inc Makrozyklische motilin rezeptorantagonisten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH672792A5 (fr) * 1985-02-19 1989-12-29 Sandoz Ag
WO1986006379A1 (fr) * 1985-04-19 1986-11-06 The Upjohn Company Inhibiteurs de renine a substitution dihalo-statine
AU3964489A (en) * 1988-07-08 1990-02-05 Smithkline Beckman Corporation Retroviral protease binding peptides
US5071837A (en) * 1990-11-28 1991-12-10 Warner-Lambert Company Novel renin inhibiting peptides
CA2098020C (fr) * 1991-01-02 2003-10-21 Daniel Schirlin Composes antiviraux
EP0773926A1 (fr) * 1994-07-15 1997-05-21 Merrell Pharmaceuticals Inc. Agents antiviraux a base de difluorostatone

Also Published As

Publication number Publication date
JP3574455B2 (ja) 2004-10-06
FI963073A7 (fi) 1996-08-02
ATE198602T1 (de) 2001-01-15
CA2182476C (fr) 2000-12-26
JPH09508417A (ja) 1997-08-26
KR100367379B1 (ko) 2003-04-11
HUT74384A (en) 1996-12-30
ES2155515T3 (es) 2001-05-16
NO963254D0 (no) 1996-08-02
AU1262295A (en) 1995-08-21
AU684875B2 (en) 1998-01-08
NZ277410A (en) 1997-02-24
IL112514A0 (en) 1995-05-26
ZA95756B (en) 1995-10-05
EP0742791A1 (fr) 1996-11-20
NO963254L (no) 1996-08-02
DE69426574D1 (de) 2001-02-15
WO1995021186A1 (fr) 1995-08-10
PT742791E (pt) 2001-06-29
EP0742791B1 (fr) 2001-01-10
DK0742791T3 (da) 2001-04-02
CN1142830A (zh) 1997-02-12
DE69426574T2 (de) 2001-08-09
US5969132A (en) 1999-10-19
FI963073A0 (fi) 1996-08-02
GR3035623T3 (en) 2001-06-29
HU9602158D0 (en) 1996-09-30

Similar Documents

Publication Publication Date Title
NO20010047D0 (no) Antivirale makrocykliske forbindelser
FI954829L (fi) Aroyylipiperidiinijohdannaiset
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
DK0891332T3 (da) 6-phenylpyridyl-2-aminderivater
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
FI945042A7 (fi) 1-piperatsino-1,2-dihydroindeenijohdannaiset
FI952424L (fi) 11,21-bisfenyyli-19-norpregaanijohdannaisia
ATE212635T1 (de) 1,3,8-triazaspiro(4,5)decan-4-on-derivate
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
PT922050E (pt) Derivados de 3-descladinose-2,3-anidroeritromicina
BR9509793A (pt) Derivados de tiofeneno
FI971227A7 (fi) Pyramidinyylipyratsolijohdannaisia
ATE204279T1 (de) Diaza-spiro(3,5)nonan-derivate
DE69527786D1 (de) Diaminomethyliden-derivate
FI964853A7 (fi) Deasetoksitaksolijohdannaiset
FI972585L (fi) Virustenvastaisina aineina käyttökelpoiset tienoksatsinonijohdannaiset
TR28915A (tr) Naftokinon türevleri.
BR9505177A (pt) Derivados de ciclolignan antineoplásticos
BR9506618A (pt) Derivados de difeniloxazolinas
ATE193300T1 (de) 14alpha,17alpha-c2-überbrückte 19-nor- progesteronderivate
FI955026A7 (fi) Alkyyli-5-metyylisulfonyylibentsoyyliguanidiinijohdannaisia
FI964468L (fi) Adenosiinijohdannaisia
BR9509877A (pt) Novos derivados de pirimidinilóxi-e piridimidinilamino- etilfenil-dioxolano
FI963073A7 (fi) Makrosykliset difluorisatonijohdannaiset, jotka ovat käyttökelpoisia v iruksia vastustavina aineina
BR9701404A (pt) Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol

Legal Events

Date Code Title Description
MA Patent expired